Matthew Chen - McDermott Will & Emery

Overview


Matthew Chen focuses his practice on UK and international private equity investments and buyout transactions, acting for institutions, private family offices, and portfolio companies. Matthew advises corporate clients on cross-border mergers and acquisitions, joint ventures and corporate reorganisations. He also advises start-up and growth stage companies on structuring and investment rounds.

Show More

Results


  • Represented Praxair, Inc. in the USD 3.3 billion divestment of North American and South American assets by Praxair, Inc. and Linde AG to Messer and CVC Capital Partners Fund VII. The divestments were subject to regulatory approvals and required for the consummation of the USD 90 billion Praxair-Linde merger
  • Advised on the EUR 5 billion divestment of the majority of Praxair’s businesses in Europe to Taiyo Nippon Sanso Corporation, a company listed on the Tokyo Stock Exchange and majority owned by Mitsubishi Chemical Holdings Corporation
  • Advised Tana Africa Capital and Plexus Investments on the USD 532 million sale of interests in the Promasidor group – a pan African foods business – to Ajinomoto of Japan

Show More

Recognitions


  • IFLR1000, M&A, 2022-2023
  • The Legal 500 UK, Recommended in Corporate: M&A: Lower Mid-Market Deals, 2022
  • The M&A Advisor, “M&A Deal of the Year” International M&A Award Winner, 2019

Credentials


Education
Queen Mary University of London, LLM, 2012
College of Law, London, LPC, 2010
University College London, LLB, 2009

Admissions
Texas
England and Wales